Take Control

BEHAVIORAL3 trials

Sponsors

Boston University Charles River Campus, National Institute on Drug Abuse (NIDA)

Conditions

AddictionAlcohol DependenceAlcohol Use DisorderAnxiety Disorders

Phase 2

Semaglutide Therapy for Alcohol Reduction (STAR)

Active, not recruitingNCT06015893

National Institute on Drug Abuse (NIDA)Addiction, Alcohol Use Disorder

Start: 2023-10-17End: 2027-03-31Updated: 2026-09-02

Phase 3

Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism

CompletedNCT02901041

Boston University Charles River CampusAlcohol Dependence

Start: 2017-09-21End: 2022-01-04Updated: 2023-06-18

Unknown Phase

Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders

CompletedNCT03230006

Boston University Charles River CampusAlcohol Use Disorder, Anxiety Disorders

Start: 2018-03-01End: 2024-01-31Updated: 2025-04-09

Related Papers

Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder

Addiction Science & Clinical Practice2024-07-276 citations